Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets

02. ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)

Upside Potential: 44%

On September 5, Citigroup increased its price target for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) from $8.00 to $13.00, indicating a bullish sentiment despite the stock experiencing a 3.0% decrease. The new price target reflects a significant 44% upside potential for the stock. The new target reflects Citigroup’s optimistic outlook on ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC). This adjustment signals Citigroup’s belief that ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) may not only warrant a more favorable valuation but potentially reach the newly established target of $13.00. It suggests that Citigroup views the company’s prospects positively, despite the short-term market fluctuations.